trending Market Intelligence /marketintelligence/en/news-insights/trending/BVzkYPt8As1Oos9h0h0iYw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Axovant Sciences to raise $40M via common stock offering

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Axovant Sciences to raise $40M via common stock offering

Axovant Sciences Ltd. is planning to raise $40 million in gross proceeds through an underwritten offering of common shares.

The London-based developer of neurological and psychiatric treatments plans to issue 26,666,667 common shares for $1.50 per share as part of the offering.

Axovant Sciences also granted underwriters an option to buy up to an additional 4 million common shares. The offering is expected to close March 18.

Jefferies LLC and Guggenheim Securities LLC are acting as underwriters for the offering.